National Health Investors, Inc. (NYSE:NHI) Receives Consensus Rating of "Moderate Buy" from Analysts
National Health Investors, Inc. (NYSE:NHI) has received a consensus "Moderate Buy" rating from seven analysts, with an average one-year target price of $85.57. Institutional investors have also shown increased interest, with major firms like Vanguard Group and JPMorgan Chase & Co. significantly boosting their holdings. The company, a specialized REIT focusing on healthcare and senior housing facilities, currently trades at $88.74, boasting a market cap of $4.23 billion.
A Look At National Health Investors (NHI) Valuation After New Property Acquisitions And Analyst Rating Upgrade
National Health Investors (NHI) reached a 52-week high after announcing significant property acquisitions and investments. Despite trading near its high, the stock shows an intrinsic discount of 55.39%. The article discusses mixed signals on its valuation, with some narratives suggesting it's slightly overvalued based on earnings forecasts, while other metrics like the P/E ratio indicate it's aligned with or below the industry average.
National Health Investors (NHI) to Release Earnings on Thursday
National Health Investors (NHI) is scheduled to release its Q4 2025 earnings after market close on Thursday, February 26th, with analysts expecting $1.23 EPS and $95.12 million in revenue. The company's shares opened at $88.98, down 2.2%, with a market capitalization of $4.24 billion. Analysts currently have an average "Moderate Buy" rating with a target price of $85.57.
National Health Investors stock hits 52-week high at $90.58 By Investing.com
National Health Investors Inc. (NHI) stock has hit a 52-week high of $90.58, reflecting a 38.72% increase over the past year and a 22.49% gain in the last six months. The healthcare real estate investment trust, with a market capitalization of $4.3 billion, benefits from strategic investments and favorable market conditions, maintaining a 4.12% dividend yield for 35 consecutive years. Recent developments include the acquisition of nine healthcare properties for $105.5 million and $89.2 million in other healthcare investments, with Truist Securities raising its price target to $83.
National Health Investors stock hits 52-week high at $90.58 By Investing.com
National Health Investors (NHI) stock reached a 52-week high of $90.58, reflecting a 38.72% increase over the past year and a 22.49% gain in the last six months. The company, a healthcare real estate investment trust, has a market cap of $4.3 billion and a 4.12% dividend yield, maintaining payments for 35 consecutive years. Recent strategic investments include acquiring nine healthcare properties for $105.5 million and a 107-unit assisted living facility for $52.1 million, while Truist Securities raised its price target for NHI to $83.
National Health Investors (NYSE:NHI) Hits New 52-Week High - Here's Why
National Health Investors (NHI) recently achieved a new 52-week high of $90.58, closing at $90.41 after trading 6,531 shares. The healthcare-focused REIT, with a market cap of $4.29 billion, holds a "Moderate Buy" average analyst rating with an average target price of $85.57. Institutional investors own approximately 62.51% of the company's stock, and several analysts have recently raised their price targets for NHI.
National Health Investors stock hits 52-week high at $90.58 By Investing.com
National Health Investors Inc. (NHI) stock achieved a 52-week high of $90.58, reflecting a 38.72% increase over the past year and a 22.49% gain in the last six months, driven by favorable market conditions and strategic investments. The company, a healthcare REIT with a $4.3 billion market capitalization, maintains a 4.12% dividend yield and has made recent acquisitions totaling over $100 million in healthcare properties. Truist Securities has raised its price target for NHI to $83, reiterating a Buy rating, based on the company's expansion efforts and financial projections.
National Health Investors stock hits 52-week high at $90.58 By Investing.com
National Health Investors Inc. (NHI) stock has reached a 52-week high of $90.58, marking a 38.72% increase over the past year and 22.49% over six months. The healthcare REIT, with a market capitalization of $4.3 billion, benefits from favorable market conditions and strategic investments, including recent acquisitions totaling over $190 million. Despite a high P/E ratio, the company maintains a 4.12% dividend yield and consistent dividend payments for 35 years.
Responsive Playbooks and the NHI Inflection
This article from Stock Traders Daily discusses National Health Investors Inc. (NYSE: NHI), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines three AI-generated trading strategies—position trading, momentum breakout, and risk hedging—with specific entry, target, and stop-loss levels. The analysis also provides multi-timeframe signal analysis indicating strong signals across near-term, mid-term, and long-term horizons, accompanied by support and resistance levels.
Is NHI’s Latest Senior Housing Expansion Quietly Redefining Its Core Investment Story?
National Health Investors (NHI) has expanded its real estate portfolio by acquiring nine properties in Kentucky, South Carolina, and Tennessee, coinciding with raised earnings estimates. This expansion and positive revisions underscore the company's operational growth in senior housing, though potential occupancy and margin pressures in its SHOP segment remain the primary risk. The article suggests investors examine multiple perspectives on future performance and integrate newly acquired properties for consistent revenue.
National Health Investors (NYSE:NHI) Hits New 52-Week High - Here's What Happened
National Health Investors (NHI) shares recently hit a new 52-week high, trading as high as $87.27. Analysists maintain a "Moderate Buy" consensus rating with an average target price of $85.57, despite some firms adjusting their targets. The company, a healthcare-focused REIT with a $4.11 billion market cap, demonstrates strong fundamentals including a P/E of 27.18 and significant institutional ownership.
Allianz Asset Management GmbH Lowers Holdings in National Health Investors, Inc. $NHI
Allianz Asset Management GmbH significantly reduced its stake in National Health Investors, Inc. (NYSE:NHI) by 16.7% in Q3, selling over 20,000 shares. Despite this, five other institutional investors increased their holdings in NHI during recent quarters. The stock currently holds a "Moderate Buy" consensus rating from analysts with a target price of $85.57.
National Health Investors stock hits 52-week high at $85.20 By Investing.com
National Health Investors Inc. (NHI) stock recently achieved a new 52-week high of $85.20, reflecting a significant 26.85% increase over the past year and indicating strong investor confidence. The company has also been active in expanding its portfolio, acquiring nine healthcare properties for $105.5 million and completing $89.2 million in senior housing investments, including a notable acquisition in Jamison, Pennsylvania. Truist Securities raised its price target for NHI to $83, maintaining a Buy rating and revising its 2025 FFO estimate upward.
National Health Investors buys nine senior housing properties for $105.5M
The provided content is empty ("MSN"). Without the actual article text, it's impossible to generate a summary or cleaned content regarding National Health Investors' acquisition of senior housing properties.
A Look At National Health Investors (NHI) Valuation After Recent Share Price Momentum
National Health Investors (NHI) has seen recent momentum with its share price, with analysts valuing the stock at $85.63 against its current trading price of $81.12, suggesting it is modestly undervalued. The company's expansion in its Senior Housing Operating Portfolio (SHOP) segment is expected to drive significant NOI and earnings growth, though risks like persistent SHOP occupancy softness could impact rental income. Investors are encouraged to review the full narrative and consider potential risks.
National Health Investors buys nine senior housing properties for $105.5M
National Health Investors (NHI) has acquired nine senior housing properties from a joint venture between an affiliate of Discovery Senior Living and a Mid-Atlantic based private equity firm for $105.5 million. The deal includes eight independent living facilities and one memory care facility in Florida and Texas, adding 984 units to NHI's portfolio. The properties will be operated by Discovery Senior Living under a new master lease agreement.
A Look At National Health Investors (NHI) Valuation After Recent Share Price Momentum
National Health Investors (NHI) has seen recent positive share price momentum, with returns of 5.56% in one month and 25.14% over one year, prompting investors to scrutinize its valuation. The stock is currently trading at $81.12, considered 5.3% undervalued compared to an analyst target of $85.63, largely due to projected double-digit NOI growth in its Senior Housing Operating Portfolio (SHOP) segment. However, this valuation could be tested if SHOP occupancy weakens or key tenants face difficulties.
How NHI’s New US$89.2 Million Senior Housing Investments Will Impact National Health Investors (NHI) Investors
National Health Investors (NHI) recently completed US$89.2 million in healthcare investments, including the acquisition of a 107-unit assisted living and memory care community with a 5-year lease. This move reinforces NHI's commitment to senior housing and its income stream, but also increases exposure to operator and funding risk due to its high debt level. While the stock has risen and may be undervalued, investors should consider the implications of debt and dividend resilience.
National Health Investors Expands SHOP With US$105.5m Senior Housing Deal
National Health Investors (NYSE:NHI) has acquired nine senior housing properties for US$105.5 million across Kentucky, South Carolina, and Tennessee, expanding its Senior Housing Operating Portfolio (SHOP). This move, managed by Allegro Living Management, increases NHI's direct exposure to operational performance rather than just collecting rent, aligning with its strategy to grow long-term cash flow from senior housing. The acquisition also highlights the company's active capital deployment into operating assets and its focus on navigating potential integration and tenant concentration risks.
National Health Investors Expands SHOP With US$105.5m Senior Housing Deal
National Health Investors (NHI) has expanded its Senior Housing Operating Portfolio (SHOP) by acquiring nine senior housing properties for US$105.5 million. These properties, totaling 460 units, will be managed by Allegro Living Management. This strategic move increases NHI's direct exposure to operational performance in the senior housing market and aligns with its ongoing effort to grow its SHOP segment.
National Health Investors buys nine senior housing properties for $105.5M
National Health Investors (NHI) has acquired nine senior housing properties for $105.5 million. This strategic move aims to expand NHI's portfolio within the senior housing market. The acquisition is expected to contribute to the company's long-term growth and solidify its position in the healthcare real estate sector.
NHI Announces $105.5 Million SHOP Investment
National Health Investors, Inc. (NHI) has announced an investment of $105.5 million, including transaction costs, for the acquisition of nine properties. These properties, located in Kentucky, comprise a total of 460 units. This strategic investment expands NHI's portfolio within the seniors housing operating (SHOP) sector.
460 senior housing units sold in $105.5M deal in KY, SC, TN
National Health Investors (NYSE:NHI) has acquired nine senior housing properties comprising 460 units across Kentucky, South Carolina, and Tennessee for $105.5 million. These properties will be integrated into NHI's Senior Housing Operating Portfolio (SHOP) and managed by Allegro Living Management, with an expected initial NOI yield of approximately 8.0%. NHI anticipates an additional $3.3 million investment in the first year and has identified further investment opportunities through signed letters of intent and an evaluated pipeline.
NHI Announces $105.5 Million SHOP Investment
National Health Investors, Inc. (NHI) has announced a $105.5 million investment, including transaction costs, to acquire nine properties with 460 units across Kentucky, South Carolina, and Tennessee. This acquisition will expand NHI's Senior Housing Operating Portfolio (SHOP) segment, managed by Allegro Living Management. The properties are anticipated to generate an initial NOI yield of approximately 8.0%.
NHI Announces $105.5 Million SHOP Investment
National Health Investors, Inc. (NHI) announced a $105.5 million investment for the acquisition of nine properties, totaling 460 units, across Kentucky, South Carolina, and Tennessee. These properties will be managed by Allegro Living Management, an affiliate of Spring Arbor Management, and are expected to generate an initial NOI yield of 8.0% to 8.6%. NHI also disclosed approximately $108.5 million in signed letters of intent for additional investments and an incremental investment pipeline of about $200 million in senior housing.
Woodmont Investment Counsel LLC Boosts Stake in National Health Investors, Inc. $NHI
Woodmont Investment Counsel LLC significantly increased its stake in National Health Investors (NHI) by 23.9% in the third quarter, bringing its total holdings to 96,287 shares valued at approximately $7.66 million. Other institutional investors also adjusted their positions, contributing to institutional ownership of 62.51% of the company. NHI reported better-than-expected Q3 EPS of $1.32 and provided optimistic FY2025 EPS guidance, while the REIT maintains an annualized dividend of $3.68, yielding about 4.5%.
National Health Investors acquires nine properties for $105.5 million By Investing.com
National Health Investors (NYSE:NHI) has acquired nine healthcare properties for $105.5 million, expanding its Senior Housing Operating Portfolio. The REIT plans to invest an additional $3.3 million in these properties, which are expected to generate an initial NOI yield of approximately 8.0%. This expansion aligns with NHI's strong financial health and growth trajectory, as indicated by its revenue growth and stock price performance.
How NHI’s New US$89.2 Million Senior Housing Investments Will Impact National Health Investors (NHI) Investors
National Health Investors (NHI) recently completed US$89.2 million in healthcare investments, including acquiring a 107-unit assisted living and memory care community with a 5-year lease. This expansion strengthens NHI's focus on senior housing and long-term income streams but also increases exposure to operator and funding risk due to existing high debt levels. Investors should monitor NHI's upcoming earnings release in February 2026 for updates on occupancy, rent coverage, and dividend commentary, while also considering the impact of debt management and lease risk on its future performance.
National Health Investors (NYSE:NHI) Hits New 12-Month High - Time to Buy?
National Health Investors (NHI) recently reached a new 52-week high of $81.88, driven by positive analyst actions and exceeding earnings estimates. Despite beating Q3 EPS expectations and offering a 4.5% dividend yield, the company faces potential sustainability concerns due to its high dividend payout ratio of 116%. Analysts currently maintain a "Moderate Buy" consensus rating with an average target price of $85.57.
National Health Investors stock hits 52-week high at $81.56
National Health Investors Inc. (NHI) stock has reached a new 52-week high of $81.56, demonstrating a significant 24.26% total return over the past year. The real estate investment trust, which focuses on senior housing and medical properties, has benefited from strategic investments and a favorable market, maintaining a 4.56% dividend yield for 35 consecutive years. This milestone reflects strong investor confidence in NHI's growth prospects and its ability to capitalize on demographic trends in healthcare.
National Health Investors stock hits 52-week high at $81.56 By Investing.com
National Health Investors Inc. (NHI) stock has reached a new 52-week high of $81.56, reflecting a 24.26% total return over the past year. The company, a real estate investment trust specializing in senior housing and medical properties, boasts a market capitalization of $3.88 billion and has maintained dividend payments for 35 consecutive years, offering a 4.56% dividend yield. This performance follows strategic investments, including a recent $89.2 million in healthcare investments and an upward adjustment in its price target by Truist Securities.
National Health Investors stock hits 52-week high at $81.56 By Investing.com
National Health Investors Inc. (NHI) stock has reached a 52-week high of $81.56, marking a 24.26% total return over the past year. The real estate investment trust, specializing in senior housing and medical properties, has a market cap of $3.88 billion and a 4.56% dividend yield, maintaining payments for 35 consecutive years. This milestone reflects investor confidence in NHI's growth prospects, supported by recent strategic investments and strong Q3 2025 earnings.
NHI Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates
National Health Investors, Inc. (NYSE:NHI) has announced that it will release its fourth-quarter 2025 earnings after the market closes on Thursday, February 26, 2026. A conference call to discuss these results will be held on Friday, February 27, 2026, at 10:00 a.m. Eastern Time. Investors can access the call via phone or live online broadcast.
NHI Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates
National Health Investors, Inc. (NHI) has announced the details for its fourth-quarter 2025 earnings release and an upcoming conference call. The earnings will be released after market close on Thursday, February 26, 2026, followed by a conference call on Friday, February 27, 2026, at 10:00 a.m. Eastern Time to discuss the results. NHI specializes in sale-leaseback, joint venture, mortgage, and mezzanine financing of senior housing and medical facility investments.
Strs Ohio Boosts Holdings in National Health Investors, Inc. $NHI
Strs Ohio significantly increased its stake in National Health Investors (NHI) by 293.6% in Q3, now holding 167,300 shares worth $13.3 million. The REIT reported Q3 EPS of $1.32, beating estimates, and declared a quarterly dividend of $0.92, translating to a 4.6% yield. Analysts currently rate NHI as a "Moderate Buy" with a consensus price target of $85.57.
National Health Investors, Inc. (NYSE:NHI) Receives Consensus Rating of "Moderate Buy" from Brokerages
National Health Investors, Inc. (NYSE:NHI) has received a consensus "Moderate Buy" rating from seven brokerages, with an average 1-year price target of $85.57. Institutional investors, including Vanguard and JPMorgan, have significantly increased their holdings in the real estate investment trust. NHI also announced a quarterly dividend of $0.92 per share, representing an annualized yield of 4.6%, despite a high payout ratio of 116.09%.
The Technical Signals Behind (NHI) That Institutions Follow
This article from Stock Traders Daily analyzes National Health Investors Inc. (NHI) using AI models to provide technical signals for institutional trading. It highlights a near-term neutral sentiment amidst mid and long-term strength, an exceptional risk-reward setup targeting a 4.6% gain, and offers three distinct trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal strengths and support/resistance levels for NHI.
Deutsche Bank Downgrades National Health Farmers Inc(NHI.US) to Hold Rating, Cuts Target Price to $85
Deutsche Bank has downgraded National Health Investors Inc (NHI.US) to a "hold" rating and adjusted its target price from $90 to $85. Analyst Omotayo Okusanya made this change. The analyst has a 60.5% success rate and an 8.6% average return over the past year, according to TipRanks data.
Will Jamison Assisted Living Deal and Q3 Beat Shift National Health Investors' (NHI) Long‑Term Narrative?
National Health Investors (NHI) recently completed a $89.2 million investment, including a $52.1 million acquisition of an assisted living facility in Jamison, Pennsylvania, and beat Q3 2025 EPS estimates despite lower revenue. This suggests operational resilience and a focus on expanding its senior housing operating portfolio. The company's future performance hinges on stabilizing occupancy and successful integration of new assets, with a projected revenue of $427.5 million by 2028.
National Health Investors stock hits 52-week high at $80.68 By Investing.com
National Health Investors Inc. (NHI) stock reached a new 52-week high of $80.68, reflecting strong investor confidence and positive market sentiment. The company, a real estate investment trust specializing in senior housing and medical properties, has delivered a 21.82% total return over the past year and maintains a 4.64% dividend yield with 35 consecutive years of dividend payments. Despite being slightly overvalued according to InvestingPro, NHI boasts a "GREAT" financial health score and has recently reported exceeding Q3 2025 EPS expectations while completing significant healthcare investments.
Will Jamison Assisted Living Deal and Q3 Beat Shift National Health Investors' (NHI) Long‑Term Narrative?
National Health Investors (NHI) recently completed significant healthcare investments, including a US$52.1 million acquisition of an assisted living facility in Jamison, Pennsylvania. This, coupled with better-than-expected Q3 2025 earnings per share, highlights the company's operational resilience. The new acquisition is particularly important as it expands NHI's senior housing operating portfolio, aligning with a strategy focused on occupancy trends and execution in newly acquired properties.
A Look At National Health Investors (NHI) Valuation After New Investments And Earnings Beat
National Health Investors (NHI) is gaining attention after securing US$89.2 million in healthcare investments and exceeding third-quarter earnings per share expectations, despite revenue falling short. The stock is currently trading near its 52-week high, with analysts suggesting an intrinsic value of US$86 per share, indicating potential undervaluation. The company's future growth is expected to be driven by increasing demand from the 75+ U.S. population and improved occupancy and pricing power in its senior housing portfolio.
A Look At National Health Investors (NHI) Valuation After New Investments And Earnings Beat
National Health Investors (NHI) is receiving attention after making significant healthcare investments and exceeding earnings per share forecasts. Despite trading near its 52-week high, analysts suggest it is undervalued with a fair value of US$86 per share due to projected growth in the 75+ U.S. population and increased demand for senior housing, although risks like softer occupancy or underperforming acquisitions remain.
A Look At National Health Investors (NHI) Valuation After New Investments And Earnings Beat
National Health Investors (NHI) has seen its valuation increase after completing significant healthcare investments and reporting better-than-expected quarterly earnings per share. Despite revenue falling below forecasts, the stock is trading near its 52-week high with a 6.8% undervaluation according to analysts, suggesting potential for further upside. The company benefits from accelerating growth in the senior population and increased demand for senior housing, although risks like softer occupancy and tenant underperformance remain.
National Health Investors stock hits 52-week high at $80.68 By Investing.com
National Health Investors Inc. (NHI) stock reached a new 52-week high at $80.68, reflecting significant investor confidence and a 21.82% total return over the past year. The healthcare REIT, with a $3.84 billion market capitalization, maintains a 4.64% dividend yield and has sustained dividend payments for 35 consecutive years. Despite being slightly overvalued according to InvestingPro, NHI demonstrates strong financial health and recently reported mixed Q3 2025 earnings, exceeding EPS expectations while revenue fell short, alongside completing $89.2 million in healthcare investments.
National Health Investors stock hits 52-week high at $80.68 By Investing.com
National Health Investors (NHI) stock reached a new 52-week high at $80.68, reflecting strong investor confidence and a 21.82% return over the past year. The healthcare REIT maintains a 4.64% dividend yield and has consistently paid dividends for 35 years. Although InvestingPro analysis suggests it's slightly overvalued, NHI holds a "GREAT" financial health score and recently completed $89.2 million in healthcare investments.
Precision Trading with National Health Investors Inc. (NHI) Risk Zones
This article from Stock Traders Daily provides a detailed analysis of National Health Investors Inc. (NHI) using AI-generated predictive insights. It highlights a strong near-term sentiment shifting to a long-term positive bias, with specific support and resistance levels. The report also outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, emphasizing an exceptional risk-reward setup targeting a 4.5% gain.
National Health Investors invests $74.3M to add 344 units in Oklahoma and Oregon to portfolio
National Health Investors has invested $74.3 million to acquire two senior housing communities, adding 344 units to its portfolio in Oklahoma and Oregon. This acquisition diversifies their holdings and showcases their continued strategic investments in healthcare properties.
National Health Investors invests $74.3M to add 344 units in Oklahoma and Oregon to portfolio
National Health Investors (NHI) has expanded its portfolio by acquiring two senior living campuses for $74.3 million. This acquisition adds 344 units across properties in Oklahoma and Oregon, increasing NHI's presence in the senior housing market.
A Look At National Health Investors (NHI) Valuation After Recent Share Price Strength
National Health Investors (NHI) has seen recent share price strength, closing at $78.01, with analysts suggesting a fair value of $86.25, indicating it is undervalued. The company's focus on its Senior Housing Operating Portfolio (SHOP) segment and projected double-digit NOI growth are key drivers for its valuation. Investors are encouraged to consider the potential for growth, while also acknowledging risks such as persistent softness in SHOP occupancy.
